The market is segmented based on , By Type (Synthetic, Biological), Application (Gall Stones, Primary Biliary Cholangitis), Mode (In-house, Contract Manufacturing), Use (Human, Veterinary) – Industry Trends and Forecast to 2031.
.
The Global Ursodeoxycholic Acid Market size was valued at USD 580.00 USD Million in 2023.
The Global Ursodeoxycholic Acid Market is projected to grow at a CAGR of 10.1% during the forecast period of 2024 to 2031.
The major players operating in the market include ICE S.p.a. , Merck KGa, Daewoong Bio , Glenmark Pharmaceuticals Ltd , Dipharma Francis S.r.l. , IOL Chemicals and Pharmaceuticals, Kimia Biosciences Ltd &ndash, , Cerata Pharmaceuticals , Changde Yungang Biotechnology Co. Ltd. , Osmopharm SA, Tianjin NWS Biotechnology and Medicine Co. Ltd, Zhongshan Belling Biotechnology Co. Ltd. , Axplora, Anant Pharmaceuticals Pvt Ltd .
The market report covers data from the U.S., Canada, Mexico, U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey, Rest of Europe, China, South Korea, Japan, India, Australia, Singapore, Malaysia, Indonesia, Thailand, Philippines, Rest of Asia-Pacific, South Africa, Rest of Middle East and Africa, Brazil, and Rest of South America.
Corporate Email ID Only (Avoid Using Generic mail ID such as Gmail)
Consent Preferences
We use cookies to improve your experience We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site, or closing this box, you consent to our use of cookies. Cookie Notice.
The data presented is for visualization purposes only and may not reflect actual results.